Long Term Follow up of Water Vapor Thermal Therapy (Rezum) for Benign Prostatic Hyperplasia (BPH)

Last updated: June 24, 2025
Sponsor: Helwan University
Overall Status: Completed

Phase

N/A

Condition

Prostate Disorders

Bladder Disorders

Treatment

water vapor thermal therapy (Rezum) for prostate

Clinical Study ID

NCT05982444
30-2023
  • Ages 40-80
  • Male

Study Summary

This study aims to assess the effectiveness and morbidity of water vapor thermal therapy (Rezūm therapy) for benign prostatic hyperplasia (BPH). Data will be collected and analyzed from patients treated by Rezūm and followed up for 4 years prior to evaluating clinical outcomes.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • patients underwent rezum procedure for benign prostatic hyperplasia from 2 to 4years

Exclusion

Exclusion Criteria:

  • previous prostatic intervention

  • concurrent urological morbidity like urethral stricture

  • neurological disease like parkinson's disease

Study Design

Total Participants: 86
Treatment Group(s): 1
Primary Treatment: water vapor thermal therapy (Rezum) for prostate
Phase:
Study Start date:
March 01, 2021
Estimated Completion Date:
May 01, 2025

Study Description

The investigators will conduct a retrospective study evaluating patients treated with water vapor thermal therapy (Rezūm therapy) for BPH and followed up for4 years. The primary objectives are to assess the long-term effectiveness and morbidity rates associated with the procedure. Data collected will include urinary symptom scores, sexual function, and any treatment-related complications.

Connect with a study center

  • Faculty of Medicine Helwan University

    Helwan, Cairo 11795
    Egypt

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.